Increase in gross profit margin from 14.93% to 15.67%
Increase in gross profit of 13% to R1.54 billion (2021: R1.36 billion)
Successful conclusion of the Cell C recapitalisation transaction in September 2022
Core headline earnings of 3.94 cents per share** (2021: 62.69 cents per share)
